Sleep Apnea
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Hyperpnea and Hyperventilation
Chronic Obstructive Pulmonary Disease
Other Pulmonary Disorders
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 14, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
George-Cosmin Popovici1,2, Costinela-Valerica Georgescu3,4, Mihaela-Camelia Vasile1,5
1School for Doctoral Studies in Biomedical Sciences, "Dunarea de Jos" University from Galati, 800008 Galati, Romania.
Hospitalized COVID-19 patients frequently develop severe obstructive sleep apnea (OSA). Risk factors include male gender, age over 60, obesity, and cardiovascular issues, necessitating further sleep disorder management strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: